NYSE:EHAB - New York Stock Exchange, Inc. - US29332G1022 - Common Stock - Currency: USD
8.14
-0.3 (-3.55%)
The current stock price of EHAB is 8.14 USD. In the past month the price increased by 1.5%. In the past year, price decreased by -14.23%.
Symbol | Name | TA | FA | PE | Market Cap |
---|---|---|---|---|---|
CI | THE CIGNA GROUP | 10.97 | 82.08B | ||
CVS | CVS HEALTH CORP | 11.71 | 79.88B | ||
LH | LABCORP HOLDINGS INC | 17.15 | 20.84B | ||
DGX | QUEST DIAGNOSTICS INC | 19.1 | 19.12B | ||
FMS | FRESENIUS MEDICAL CARE-ADR | 13.74 | 13.55B | ||
BTSGU | BRIGHTSPRING HEALTH SERV - BTSG 6 3/4 02/01/27 | 148.77 | 12.18B | ||
DVA | DAVITA INC | 14.99 | 11.68B | ||
HIMS | HIMS & HERS HEALTH INC | 112 | 10.77B | ||
CHE | CHEMED CORP | 23.84 | 8.18B | ||
CRVL | CORVEL CORP | 25.97 | 5.57B | ||
OPCH | OPTION CARE HEALTH INC | 26.89 | 5.45B | ||
GH | GUARDANT HEALTH INC | N/A | 5.30B |
Enhabit, Inc. functions as an investment holding company. The company is headquartered in Dallas, Texas and currently employs 10,800 full-time employees. The company went IPO on 2022-06-23. The Company’s segments include Home Health and Hospice. The Home Health segment provides a range of Medicare-certified skilled home health services, including skilled nursing, physical, occupational and speech therapy, medical social work, and home health aide services. Its home health business benefits from a diversity of referral sources, with patients referred from acute care hospitals, inpatient rehabilitation facilities, surgery centers, assisted living facilities, and skilled nursing facilities, as well as community physicians. The Hospice segment provides hospice services for terminally ill patients and their families. Its Medicare-certified hospice operations provide hospice services, including pain and symptom management, palliative and dietary counseling, social worker visits, spiritual counseling, and family member bereavement counseling. The company operates over 110 hospice agencies and 255 home health agencies.
ENHABIT INC
6688 N. Central Expressway, Suite 1300
Dallas TEXAS US
Employees: 10800
Company Website: https://www.ehab.com/
Investor Relations: https://investors.ehab.com/
Phone: 14696216419
The current stock price of EHAB is 8.14 USD. The price decreased by -3.55% in the last trading session.
The exchange symbol of ENHABIT INC is EHAB and it is listed on the New York Stock Exchange, Inc. exchange.
EHAB stock is listed on the New York Stock Exchange, Inc. exchange.
12 analysts have analysed EHAB and the average price target is 9.08 USD. This implies a price increase of 11.52% is expected in the next year compared to the current price of 8.14. Check the ENHABIT INC stock analysts ratings, price target forecast and up-and down grades for more detailed information.
ENHABIT INC (EHAB) has a market capitalization of 409.28M USD. This makes EHAB a Small Cap stock.
ENHABIT INC (EHAB) currently has 10800 employees.
ENHABIT INC (EHAB) has a support level at 8.1 and a resistance level at 8.16. Check the full technical report for a detailed analysis of EHAB support and resistance levels.
The Revenue of ENHABIT INC (EHAB) is expected to decline by -1.03% in the next year. Check the estimates tab for more information on the EHAB EPS, Sales, EBIT and EBITDA future analyst estimates.
There is no straightforward answer here. It depends on your investment strategy as different types of investors will look at different aspects. In any case it is important to make an informed decision and these pages can help you forming an opinion:
EHAB does not pay a dividend.
ENHABIT INC (EHAB) will report earnings on 2025-03-05, after the market close.
The PE ratio for ENHABIT INC (EHAB) is 35.39. This is based on the reported non-GAAP earnings per share of 0.23 and the current share price of 8.14 USD. Check the full fundamental report for a full analysis of the valuation metrics for EHAB.
The outstanding short interest for ENHABIT INC (EHAB) is 2.55% of its float. Check the ownership tab for more information on the EHAB short interest.
ChartMill assigns a technical rating of 5 / 10 to EHAB. When comparing the yearly performance of all stocks, EHAB is a bad performer in the overall market: 67.97% of all stocks are doing better.
ChartMill assigns a fundamental rating of 2 / 10 to EHAB. EHAB may be in some trouble as it scores bad on both profitability and health.
Over the last trailing twelve months EHAB reported a non-GAAP Earnings per Share(EPS) of 0.23. The EPS decreased by -52.08% compared to the year before.
Industry Rank | Sector Rank | ||
---|---|---|---|
PM (TTM) | N/A | ||
ROA | -8.94% | ||
ROE | -20.6% | ||
Debt/Equity | 0.89 |
ChartMill assigns a Buy % Consensus number of 75% to EHAB. The Buy consensus is the average rating of analysts ratings from 12 analysts.
For the next year, analysts expect an EPS growth of 3.54% and a revenue growth -1.03% for EHAB